Although no cases have been reported in humans, the medication is still contraindicated for patients with their own or family history of thyroid or neuroendocrine tumors
As usual Professor Galloway has been worthwhile following as he informed me early in the GLP-1 adoption curve to pay attention to what has gone beyond a medical trend to a cultural and economic phenomenon
To understand the durability and stability of weight outcomes after stopping GLP-1s, we studied 188,722 patients who stopped using a GLP-1 medication after being on it for at least 90 days and who lost at least 5 pounds while on it
During the GLP-1 drug shortages that stretched across several years, FDA-registered outsourcing facilities played an important role in helping meet patient demand when commercially available options were unavailable
At US Fit Clinic, we believe in a simpler, more effective way to lose fat and transform your body
Abdelrazik H, Sharma R, Mahfouz R, Agarwal A